$CRXM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Gene Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Gene Biotherapeutics, Inc.. Get notifications about new insider transactions in Gene Biotherapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | CRXM | Gene Biotherapeuti ... | Jemapete Christopher J | 10% Owner | Buy | P | 0.40 | 200,000 | 80,400 | 4,000,000 | 3.8 M to 4 M (+5.26 %) |
| Mar 18 2021 | CRXM | Gene Biotherapeuti ... | Jemapete Christopher J | 10% Owner | Buy | P | 0.04 | 300,000 | 11,970 | 3,800,000 | 3.5 M to 3.8 M (+8.57 %) |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | LEWIS GERALD J | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Gabrielson Edward W | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Otremba Lon E | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | HUTCHISON MURRAY H | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Leitch Andrew M | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | REINHARD CHRISTOPHER J | Chief Executive Off ... | Option Exercise | J | 0.60 | 400,000 | 240,000 | 984,475 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | LEWIS GERALD J | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | REINHARD CHRISTOPHER J | Chief Executive Off ... | Option Exercise | J | 0.80 | 548,550 | 438,840 | 548,550 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | HUTCHISON MURRAY H | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Otremba Lon E | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Leitch Andrew M | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Gabrielson Edward W | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | J | 0.80 | 50,000 | 40,000 | 80,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Rubanyi Gabor M | Chief Scientific Of ... | Option Exercise | J | 0.80 | 50,000 | 40,000 | 53,350 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Dylan Tyler Michael | Chief Business Offi ... | Option Exercise | J | 0.80 | 448,550 | 358,840 | 448,550 | |
| Jun 15 2009 | CRXM | Taxus Cardium Phar ... | Rubanyi Gabor M | Chief Scientific Of ... | Option Exercise | J | 2.00 | 67,000 | 134,000 | 367,000 | |
| Mar 18 2009 | CRXM | Taxus Cardium Phar ... | Leitch Andrew M | Director | Option Exercise | A | 0.74 | 100,000 | 74,000 | 200,000 | |
| Mar 17 2009 | CRXM | Taxus Cardium Phar ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 0.74 | 325,000 | 240,500 | 600,000 | |
| Mar 17 2009 | CRXM | Taxus Cardium Phar ... | Gabrielson Edward W | Director | Option Exercise | A | 0.74 | 100,000 | 74,000 | 200,000 | |
| Mar 17 2009 | CRXM | Taxus Cardium Phar ... | Otremba Lon E | Director | Option Exercise | A | 0.74 | 100,000 | 74,000 | 200,000 | |
| Mar 17 2009 | CRXM | Taxus Cardium Phar ... | LEWIS GERALD J | Director | Option Exercise | A | 0.74 | 100,000 | 74,000 | 200,000 | |
| Mar 17 2009 | CRXM | Taxus Cardium Phar ... | HUTCHISON MURRAY H | Director | Option Exercise | A | 0.74 | 100,000 | 74,000 | 200,000 | |
| Feb 02 2009 | CRXM | Taxus Cardium Phar ... | SIMON RONALD I | Option Exercise | J | 2.75 | 25,012 | 68,783 | 74,988 | ||
| Nov 12 2008 | CRXM | Taxus Cardium Phar ... | REINHARD CHRISTOPHER J | Chief Executive Off ... | Option Exercise | J | 2.00 | 718,500 | 1,437,000 | 718,500 | |
| Nov 12 2008 | CRXM | Taxus Cardium Phar ... | Rubanyi Gabor M | Chief Scientific Of ... | Option Exercise | J | 2.00 | 300,000 | 600,000 | 300,000 | |
| Nov 12 2008 | CRXM | Taxus Cardium Phar ... | Dylan Tyler Michael | Chief Business Offi ... | Option Exercise | J | 2.00 | 300,000 | 600,000 | 300,000 | |
| Aug 11 2008 | CRXM | Taxus Cardium Phar ... | Moreadith Randall | Option Exercise | J | 2.75 | 140,692 | 386,903 | 312,470 | ||
| Aug 11 2008 | CRXM | Taxus Cardium Phar ... | Moreadith Randall | Option Exercise | J | 2.75 | 46,838 | 128,805 | 72,726 | ||
| Nov 02 2007 | CRXM | Taxus Cardium Phar ... | Magers Michael | President/COO of Su ... | Buy | J | 0.00 | 15,263 | 0 | 104,121 | 88.9 K to 104.1 K (+17.18 %) |
| Apr 13 2007 | CRXM | Taxus Cardium Phar ... | Magers Michael | President/COO of Su ... | Buy | J | 0.00 | 88,858 | 0 | 88,858 | 0 to 88.9 K |
| Nov 21 2005 | CRXM | Taxus Cardium Phar ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 1.95 | 275,000 | 536,250 | 275,000 | |
| Oct 25 2005 | CRXM | Taxus Cardium Phar ... | ZUCKER MARK S | 10% Owner | Option Exercise | A | 1.75 | 400,000 | 700,000 | 400,000 | |
| Oct 25 2005 | CRXM | Taxus Cardium Phar ... | ZUCKER MARK S | 10% Owner | Option Exercise | J | 0.25 | 176,590 | 44,148 | 0 | |
| Oct 24 2005 | CRXM | Taxus Cardium Phar ... | WEINGARTEN ROBERT N | PRESIDENT and CFO | Option Exercise | J | 0.23 | 141,327 | 32,505 | 0 | |
| Oct 24 2005 | CRXM | Taxus Cardium Phar ... | KOSSUTH SELWYN | Director | Option Exercise | J | 0.23 | 17,666 | 4,063 | 0 | |
| Oct 24 2005 | CRXM | Taxus Cardium Phar ... | MILAN DIVO | Director | Option Exercise | J | 0.23 | 17,666 | 4,063 | 0 |
Page: 1